GeneFerm Biotechnology Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 231.89 million compared to TWD 153.72 million a year ago. Net income was TWD 46.81 million compared to TWD 30.02 million a year ago. Basic earnings per share from continuing operations was TWD 1.13 compared to TWD 0.72 a year ago. Diluted earnings per share from continuing operations was TWD 1.13 compared to TWD 0.72 a year ago.
For the six months, sales was TWD 415.66 million compared to TWD 297.63 million a year ago. Net income was TWD 77.28 million compared to TWD 50.52 million a year ago. Basic earnings per share from continuing operations was TWD 1.86 compared to TWD 1.23 a year ago. Diluted earnings per share from continuing operations was TWD 1.86 compared to TWD 1.17 a year ago.